Stock Analysis

Tecan Group Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

Source: Shutterstock

Tecan Group (VTX:TECN) Full Year 2022 Results

Key Financial Results

  • Revenue: CHF1.14b (up 21% from FY 2021).
  • Net income: CHF121.1m (flat on FY 2021).
  • Profit margin: 11% (down from 13% in FY 2021). The decrease in margin was driven by higher expenses.
  • EPS: CHF9.53 (down from CHF9.95 in FY 2021).
SWX:TECN Earnings and Revenue Growth March 16th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Tecan Group Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.8%. Earnings per share (EPS) missed analyst estimates by 9.0%.

Looking ahead, revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Life Sciences industry in Switzerland.

Performance of the Swiss Life Sciences industry.

The company's shares are down 1.3% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Tecan Group's balance sheet.

Valuation is complex, but we're helping make it simple.

Find out whether Tecan Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis